Jules L Dienstag Selected Research

Jules L Dienstag Research Topics

Disease

39	Fibrosis (Cirrhosis) 01/2018 - 03/2002
30	Hepatitis C 10/2021 - 04/2004
24	Chronic Hepatitis C 04/2012 - 03/2002
11	Liver Diseases (Liver Disease) 01/2018 - 12/2003
11	Chronic Hepatitis B 08/2010 - 07/2002
7	Hepatocellular Carcinoma (Hepatoma) 01/2012 - 09/2005
6	Disease Progression 01/2012 - 11/2002
4	Liver Cirrhosis (Hepatic Cirrhosis) 09/2012 - 03/2008
4	Hepatitis B 05/2009 - 04/2003
3	Infections 01/2007 - 03/2002
2	End Stage Liver Disease 11/2019 - 01/2019
2	Alcoholic Hepatitis 01/2018 - 01/2018
2	Viremia 09/2012 - 10/2004
2	Inflammation (Inflammations) 09/2012 - 03/2002
2	Esophageal and Gastric Varices (Esophageal Varices) 02/2010 - 01/2009
2	Hepatitis 12/2003 - 11/2002
1	Persistent Infection 10/2021
1	Chronic Disease (Chronic Diseases) 11/2019
1	Necrosis 01/2018
1	Hepatorenal Syndrome 01/2018
1	Liver Neoplasms (Liver Cancer) 10/2010
1	Hepatic Encephalopathy 01/2010
1	Ascites 01/2010
1	Hemorrhage 01/2010
1	Peritonitis 01/2010
1	Hepatitis A (Hepatitis, Infectious) 05/2008
1	Anorexia 02/2008
1	Pain (Aches) 02/2008
1	Nausea 02/2008
1	Arthralgia (Joint Pain) 02/2008
1	Fatigue 02/2008
1	Body Weight (Weight, Body) 03/2002

Drug/Important Bio-Agent (IBA)

33	Antiviral Agents (Antivirals)IBA 10/2021 - 04/2004
20	Ribavirin (Virazole)FDA LinkGeneric 09/2012 - 03/2002
14	InterferonsIBA 09/2012 - 03/2002
8	Lamivudine (Epivir)FDA Link 11/2007 - 07/2002
7	Hepatitis B e AntigensIBA 08/2010 - 07/2002
6	RNA (Ribonucleic Acid)IBA 09/2012 - 03/2002
5	Biomarkers (Surrogate Marker)IBA 01/2012 - 11/2002
5	peginterferon alfa-2a (Pegasys)FDA Link 12/2008 - 04/2004
4	Alanine Transaminase (SGPT)IBA 09/2012 - 03/2002
3	NucleosidesIBA 05/2009 - 02/2005
3	entecavir FDA Link 11/2007 - 01/2006
3	adefovirIBA 11/2007 - 03/2004
2	Cytidine Triphosphate (CTP)IBA 08/2011 - 10/2010
2	Tissue Inhibitor of Metalloproteinase-1IBA 10/2010 - 03/2008
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2010 - 09/2005
2	DNA (Deoxyribonucleic Acid)IBA 05/2009 - 07/2002
2	Telbivudine FDA Link 11/2007 - 01/2006
2	Tenofovir (Viread)FDA Link 01/2006 - 03/2004
1	sofosbuvir drug combination ledipasvirIBA 10/2021
1	Prothrombin (Factor II)IBA 01/2012
1	Fetal Proteins (Fetoprotein)IBA 01/2012
1	Vitamin D FDA LinkGeneric 01/2012
1	Epidermal Growth Factor (EGF)IBA 07/2011
1	AngiotensinsIBA 02/2011
1	Antihypertensive Agents (Antihypertensives)IBA 02/2011
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 10/2010
1	Hyaluronic Acid (Hyaluronan)IBA 10/2010
1	Peptides (Polypeptides)IBA 10/2010
1	ProcollagenIBA 10/2010
1	acarboxyprothrombin (PIVKA)IBA 02/2010
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2010
1	AlbuminsIBA 01/2010
1	BilirubinIBA 01/2010
1	Coffee FDA Link 11/2009
1	TeaIBA 11/2009
1	Alkaline PhosphataseIBA 01/2009
1	VaccinesIBA 05/2008
1	CollagenIBA 03/2008
1	milk-thistle extractIBA 02/2008
1	SilymarinIBA 02/2008
1	Emtricitabine (Emtriva)FDA Link 01/2006
1	peginterferon alfa-2b (Pegintron)FDA Link 01/2006
1	Ferritins (Ferritin)IBA 09/2005
1	NucleotidesIBA 03/2004
1	adefovir dipivoxil (Hepsera)FDA Link 03/2004
1	Interferon alpha-2 (Roferon-A)FDA Link 03/2002

Therapy/Procedure

29	Therapeutics 10/2021 - 03/2002
7	Liver Transplantation 01/2018 - 02/2010
3	Retreatment 01/2007 - 04/2003
2	Palliative Care (Palliative Therapy) 11/2019 - 01/2019
2	Aftercare (After-Treatment) 11/2008 - 04/2003
1	Duration of Therapy 10/2021
1	Continuous Renal Replacement Therapy 01/2018
1	Renal Dialysis (Hemodialysis) 01/2018
1	Transplantation 01/2018
1	Drug Tapering 12/2006